[1]
S. Joy, J. Freeman, and J. LaSalle, “Tailoring treatment for type 2 diabetes: Uncovering the HOW and NOW of GLP-1 receptor agonist therapy”, OFP, vol. 3, no. 5, pp. 217–236, Sep. 2011.